We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Study Reveals the Value of CT Colonography in Determining the Growth of Polyps

By MedImaging International staff writers
Posted on 13 Jan 2016
Print article
Image: Computed Tomography Colonography (CTC) of a progressing advanced adenoma polyp in the ascending colon on 3D images (Photo courtesy of RSNA).
Image: Computed Tomography Colonography (CTC) of a progressing advanced adenoma polyp in the ascending colon on 3D images (Photo courtesy of RSNA).
Volumetric measurements of the evolution of medium-sized polyps may better inform clinicians in the management of the polyps than linear measurements.

The volumetric measurements were helpful in determining whether a patient needed a colonoscopy, or whether surveillance using Computed Tomography Colonography (CTC) was sufficient. The research was carried out at the University of Amsterdam (Amsterdam, The Netherlands) and presented at the annual Radiological Society of North America (RSNA 2015) meeting in Chicago (IL, USA).

The study had 70 participants, each with one or two 6–9 mm polyps, identified during primary CTC screening CTC. The patients underwent an additional CTC screening three year later. Patients with 6 mm or larger lesions had the opportunity to undergo colonoscopy and polypectomy. During the CTC screening exams semi-automated volumetric measurements were performed, and mean volume calculated for prone and supine volume measurements.

Polyps whose volume increased more than 30% were classified as progressing, while those that decreased more than 30% were classed as regressing. Polyps between those parameters were classed as stable. The researchers then correlated Polyp growth to histopathological findings. Thirty-five percent out of a total of 95 polyps found in the initial CTC were found to have progressed. A total of 38% of the polyps remained stable, 27% regressed, and 14% were completely resolved. During the surveillance interval none of the polyps were found to have progressed to colorectal cancers or adenomas with high-grade dysplasia.

The presenter of the study, Charlotte Tutein Nolthenius, MD, Department of Radiology, Academic Medical Center, University of Amsterdam, said, "Previous literature showed a 3–6.6% chance of harboring advanced histology for medium-sized (6–9 mm) polyps, but little is known about their natural course. CTC is probably the best method for determining longitudinal growth of these polyps, because we leave them in place allowing a reproducible localization and measurement.

Related Links:

University of Amsterdam


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ultrasound System
P20 Elite
New
X-Ray Detector
FDR-D-EVO III

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.